Presentation by the Commission on in vitro diagnostic medical devices Regulation (171442/EU XXVII.GP)

RAT: WK 1379/24 LIMITE
30.01.2024
englisch

EU-V: Berichte u. Beratungsergebnisse

Presentation by the Commission on in vitro diagnostic medical devices Regulation

Gruppe: Gruppe "Arzneimittel und Medizinprodukte"

betrifft Sitzung am 30.01.2024

Erstellt am 30.01.2024

Eingelangt am 01.02.2024, Bundesministerium für europäische und internationale Angelegenheiten

  • RAT: WK 1379/24

 Aufklappen
Datum Dok.Nr.
Art Betreff
23.01.2024 RAT: 5712/24 EUST
Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, information obligation in case of interruption of supply and the transitional provisions for certain in vitro diagnostic medical devices (170182/EU XXVII.GP)
25.01.2024 RAT: CM 1256/24 EUTO
Att. Working Party on Pharmaceuticals and Medical Devices Date: 30 January 2024 Time: 10:00 Venue: COUNCIL LEX BUILDING Rue de la Loi 145, 1048 BRUSSELS (170471/EU XXVII.GP)
30.01.2024 RAT: WK 1357/24 EUB
European Health Emergency Preparedness and Response Authority (HERA) – A new player in the global health security landscape/Presentation by the Commission (171440/EU XXVII.GP)
30.01.2024 RAT: WK 1360/24 EUB
Pharma package/Presentation by the Presidency (171441/EU XXVII.GP)
 Aufklappen
Interinstitutionelle Zahl
Link
2024/0021 COD Legislative Observatory
 Aufklappen
Dok.Nr.
Betreff
COM: COM(2024) 43 Proposal for a Regulation of the European Parliament and of the Council amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, information obligation in case of interruption of supply and the transitional provisions for certain in vitro diagnostic medical devices (Text with EEA relevance) (170265/EU XXVII.GP)
 Aufklappen
 Aufklappen
Thema
Binnenmarkt und Wettbewerb
Forschung und Innovation
Gesundheitswesen
Institutionelle Fragen
Verbraucher- und Lebensmittelsicherheit